RUNX3 and melanoma: miR-532-5p expression is upregulated in melanoma cells and metastatic melanoma tumors, and anti-miR-532-5p oligomers upregulate RUNX3 expression [31], suggesting that several different miRNAs targeting RUNX3 have specific functions in different types of cancer.